Accuray reported $-182000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US USD 2.13B 454M
Accuray ARAY:US USD -182000 3.53M
Angiodynamics ANGO:US USD 2.76M 2.82M
Atricure ATRC:US USD -7736000 2.99M
Boston Scientific BSX:US USD 814M 96M
Cardiovascular Systems CSII:US USD -9682000 1.4M
Cryolife CRY:US USD 2.28M 4.78M
Edwards Lifesciences EW:US USD 503.8M 4.1M
Hologic HOLX:US USD 286.8M 61.1M
Mesa Laboratories MLAB:US USD 11.78M 7.89M
Tandem Diabetes Care TNDM:US USD -43985000 35.3M